EMI 600Alternative Names: EMI-600
Latest Information Update: 17 Feb 2017
At a glance
- Originator Edinburgh Molecular Imaging
- Class Diagnostic agents
- Mechanism of Action Diagnostic imaging enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Lung cancer
Most Recent Events
- 17 Feb 2017 Early research in Lung cancer (Diagnosis) in United Kingdom (Parenteral) before February 2017 (Edinburgh Molecular Imaging pipeline, February 2017)